Congenital lethal myopathy, Compton-North type

Get in touch with RARE Concierge.

Contact RARE Concierge

Congenital lethal myopathy, Compton-North type

Congenital lethal myopathy Compton-North type is a rare genetic lethal non-dystrophic congenital myopathy disorder characterized antenatally by fetal akinesia intrauterine growth restriction and polyhydramnios and following birth by severe neonatal hypotonia severe generalized skeletal bulbar and respiratory muscle weakness multiple flexion contractures and normal creatine kinase serum levels. Ultrastructurally loss of integrin alpha7 beta2-syntrophin and alpha-dystrobrevin from the muscle sarcolemma and disruption of sarcomeres with disorganization of the Z band are observed.

Data from Orphanet are used to provide information on a disease's name, synonym(s), and overview.

Reference: Access aggregated data from Orphanet at Orphadata.

Orphadata: Free access data from Orphanet. © INSERM 1999. Available on http://www.orphadata.org. Data version April 2024

Newly diagnosed with
Congenital lethal myopathy, Compton-North type?

Our RARE Concierge Services Guides are available to assist you by providing information, resources and connections as you navigate your rare disease journey.

Get Concierge Help

Advocacy Organizations

Association Aux Pas du Coeur

Our organization wants to raise awareness and recognize rare diseases in Côte d'Ivoire. Our mission is to: Raising awareness and campaigning to help with the diagnosis and free therapeutic care of patients. Request and/or contribute to actions relating to the training of the medical profession so that doctors are able to make a final diagnosis and ensure the continuous follow-up of patients. Create a patient registry to establish very precise statistics of rare diseases in Côte d'Ivoire. Create a close-knit patient community. Break the isolation and despair of sick people and their families. Open up to the world and actively contribute to international research aimed at treatments.

ZC4H2 Research Foundation

Our Mission: The purpose of the ZC4H2 Research Foundation is to support the development of viable therapies and standards of clinical care for the treatment of ZC4H2 Associated Rare Disorders (ZARD), and to be an information and support network for the ZARD community. We advocate through research, awareness, and support. For more information, please visit https://www.zc4h2foundation.org.

Clinical Trials

For a list of clinical trials in this disease area, please click here.